Aurobind Pharma
Healthcare
₹845
+12.90%1Y
- Mkt cap
- ₹32,617 Cr
- P/E
- 44.0x
- Rev growth
- 13.7%
Sector
Healthcare
Pharmaceutical formulators, diagnostics chains and hospital groups, often with multi-year IPO timelines.
Industries in this sector
Prices shown are indicative, dealer-quoted and updated periodically — they are not exchange-traded prices and may differ from the price at which a transaction is finally executed.
2 companies match
RHP filed
Sundara Diagnostics
Healthcare
₹1,265
+21.70%1Y
- Mkt cap
- ₹20,493 Cr
- P/E
- 76.5x
- Rev growth
- 19.1%
Showing 1–2 of 2